Department of Paediatric Nephrology, H7-234, Emma Children's Hospital, Academic Medical Centre, Amsterdam, The Netherlands.
Department of Paediatrics, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.
Nephrol Dial Transplant. 2018 Apr 1;33(4):552-560. doi: 10.1093/ndt/gfx190.
Few data exist on the prospects in adulthood for children on chronic renal replacement therapy (RRT). This article summarizes the results of a comprehensive Dutch long-term follow-up study performed in 2000 and 2010 of patients with RRT onset at age <15 years between 1972 and 1992. After a median of 25.5 RRT years, patients had stayed 23% of RRT time on dialysis. We observed a 30 times greater mortality risk compared with age-matched peers with cardiovascular disease (CVD) as the main cause of death during 1972-2000 and infections during 2000-10. The observed shift towards infections was associated with more RRT time with a graft and receiving a stricter CVD protective treatment. For patients >40 years of age, motor disabilities affecting routine activities, skin cancer and severe fatigue were the most disabling sequelae. After 30 years of transplantation, 41% of the survivors had developed cancer, a life-threatening form of squamous cell skin carcinoma being most prevalent. Important delays in autonomy development and educational attainment and a relatively high level of unemployment were observed. Transplanted patients reported a good mental and physical quality of life, but the latter tended to decrease over time. A long period of dialysis was associated with all adverse somatic and psychosocial outcomes. Paediatric nephrologists should aim for transplantation at the earliest possible time and focus on autonomy and educational attainment. Nephrologists should focus on strict CVD prevention, adjustment of immunosuppression to the lowest possible dose and surveillance of malignancy-associated viral infections in patients with childhood end-stage renal disease.
关于接受慢性肾脏替代治疗(RRT)的儿童在成年后的前景,相关数据有限。本文总结了 2000 年和 2010 年对 1972 年至 1992 年间年龄<15 岁开始接受 RRT 的患者进行的一项全面的荷兰长期随访研究的结果。在中位 RRT 25.5 年后,患者有 23%的 RRT 时间在接受透析治疗。与同龄患有心血管疾病(CVD)的患者相比,我们观察到他们的死亡率高出 30 倍,心血管疾病是 1972-2000 年期间的主要死亡原因,而在 2000-10 年期间,感染是主要原因。观察到的向感染的转变与使用移植物的 RRT 时间延长以及接受更严格的 CVD 保护治疗有关。对于年龄>40 岁的患者,影响日常活动的运动障碍、皮肤癌和严重疲劳是最致残的后遗症。在移植 30 年后,41%的幸存者患上了癌症,最常见的是威胁生命的鳞状细胞皮肤癌。观察到自主发展和教育程度的重要延迟,以及相对较高的失业率。移植患者报告说他们的精神和身体生活质量良好,但随着时间的推移,后者往往会下降。长时间的透析与所有不良的躯体和心理社会结果都有关。儿科肾病专家应尽早进行移植,并注重自主性和教育程度。肾病专家应注重严格的 CVD 预防、将免疫抑制作用调整到最低剂量,并对儿童终末期肾病患者进行与恶性肿瘤相关的病毒感染监测。